Podcast Ep 19: Semaglutide (Ozempic) and the Rise of GLP-1 Receptors Agonists

Fri, 29 Aug 2025 12:05:48 +0000

On this episode, we review GLP-1 receptor agonists. We discuss their mechanism of action, adverse effects, and head-to-head comparison clinical trials. We also review the newly approved semaglutide (brand name Ozempic).